ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas (Q37977337)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 February 2012

Language	Label	Description	Also known as
English	ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas	scientific article published on 15 February 2012

Statements

scholarly article

1 reference

Europe PubMed Central

26 August 2017

ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas (English)

1 reference

Europe PubMed Central

26 August 2017

object named as

Thomas Gress

5

0 references

object named as

Timm Denecke

8

0 references

object named as

Aurel Perren

2

0 references

object named as

Bruno Niederle

3

0 references

Ashley Grossman

11

object named as

Ashley Grossman

1 reference

Europe PubMed Central

26 August 2017

author name string

Ulrich-Frank Pape

1

1 reference

Europe PubMed Central

26 August 2017

David Gross

4

1 reference

Europe PubMed Central

26 August 2017

Frederico Costa

6

1 reference

Europe PubMed Central

26 August 2017

Rudolf Arnold

7

1 reference

Europe PubMed Central

26 August 2017

Ursula Plöckinger

9

1 reference

Europe PubMed Central

26 August 2017

Ramon Salazar

10

1 reference

Europe PubMed Central

26 August 2017

Barcelona Consensus Conference participants

12

1 reference

Europe PubMed Central

26 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 February 2012

1 reference

Europe PubMed Central

26 August 2017

Neuroendocrinology

1 reference

Europe PubMed Central

26 August 2017

95

1 reference

Europe PubMed Central

26 August 2017

135-156

1 reference

Europe PubMed Central

26 August 2017

2

1 reference

Europe PubMed Central

26 August 2017

Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Poorly-differentiated endocrine carcinomas of midgut and hindgut origin

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Epidemiology of small bowel carcinoids in a defined population.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Small intestinal neuroendocrine tumors: prognostic factors and survival.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Survival and prognostic factor analysis of 146 metastatic neuroendocrine tumors of the mid-gut

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors: current data on a prospectively collected, retrospectively analyzed clinical multicenter investigation

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Standardisation of imaging in neuroendocrine tumours: results of a European delphi process

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Small-bowel neoplasms: prospective evaluation of MR enteroclysis

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Detection of small-bowel neuroendocrine tumors by video capsule endoscopy

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

The yield of wireless capsule endoscopy in the detection of neuroendocrine tumors in comparison with CT enteroclysis.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Diagnosis and outcome of small bowel tumors found by capsule endoscopy: a three-center Australian experience

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Detection of neuroendocrine tumors of the small bowel by double balloon enteroscopy

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Influence of attenuation correction by integrated low-dose CT on somatostatin receptor SPECT.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Impact of Multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

The importance of the measurement of circulating markers in patients with neuroendocrine tumours of the pancreas and gut.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Peptide Hormones as Tumor Markers in Neuroendocrine Gastrointestinal Tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Expression of somatostatin and dopamine 2 receptors in neuroendocrine tumours and the potential role for new biotherapies

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

First report on metastasizing small bowel carcinoids in first-degree relatives in three generations

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Abdominal Surgery in Patients with Midgut Carcinoid Tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Interventional treatment of gastrointestinal neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgical treatment of mid-gut carcinoid tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgery for midgut carcinoid

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgically treated primary malignant tumor of small bowel: a clinical analysis

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Prophylactic cholecystectomy in midgut carcinoid patients.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Factors associated with progression of carcinoid heart disease.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Echocardiographic follow-up of treated patients with carcinoid syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Fibrosis and carcinoid syndrome: from causation to future therapy

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Cardiovascular magnetic resonance imaging in the assessment of carcinoid heart disease

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Carcinoid tumour of the appendix: an analysis of 1,485 consecutive emergency appendectomies

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Carcinoid tumour of the appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Primary carcinoma of the appendix - Hull series

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Appendiceal carcinoid tumors: Predictors of lymph node metastasis and the impact of right hemicolectomy on survival

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Malignancies of the appendix: beyond case series reports

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Neuroendocrine tumours (carcinoids) of the appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Neoplastic lesions of the appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgical treatment of malignant carcinoid tumours of the appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Primary Neoplasms of the Appendix: Radiologic Spectrum of Disease with Pathologic Correlation

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Carcinoid tumours of the appendix in children 1957-1986: incidence, treatment and outcome.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Is right hemicolectomy for 2.0-cm appendiceal carcinoids justified?

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Clinicopathological features and immunoexpression profiles of goblet cell carcinoid and typical carcinoid of the appendix.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid).

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Goblet cell carcinoid of the appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Updated population-based review of carcinoid tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Methods in neuroendocrine histopathology, a methodological overview

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Goblet or signet ring cells: that is the question

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Goblet cell carcinoid of the appendix: a specific type of carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Adenocarcinoid of the appendix vermiformis: complete and persistent remission after chemotherapy (folfox) of a metastatic case

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

CK19 and CD99 Immunoexpression Profile in Goblet Cell (Mucin-Producing Neuroendocrine Tumors) and Classical Carcinoids of the Vermiform Appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Cytokeratins 7 and 20 Immunoexpression Profile in Goblet Cell and Classical Carcinoids of Appendix

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Comparison of Prognostic Value of Tissue Doppler Imaging in Carcinoid Heart Disease Versus the Value in Patients With the Carcinoid Syndrome but Without Carcinoid Heart Disease

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Surgery for carcinoid tumours of the lower gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Survival From Malignant Digestive Endocrine Tumors in England and Wales: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Early and Late Results of Valvular Surgery for Carcinoid Heart Disease

1 reference

https://api.crossref.org/works/10.1159%2F000335629

21 January 2018

Identifiers

10.1159/000335629

1 reference

Europe PubMed Central

26 August 2017

1 reference

Europe PubMed Central

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37977337&oldid=2063413161"